Generic dapagliflozin is now approved for adults with type 2 diabetes, though current labeling excludes chronic kidney disease and pediatric use.

203 kava exposures reported in 2025; reports involving combined use of kava and kratom reached 30 percent of all kava reports in 2025 ...

HealthDay News — Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a study published online March ...

HealthDay News — The US is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Officials say tariffs could reach as high as 100% on certain ...

Budoprutug is an investigational, humanized monoclonal antibody designed to selectively target and bind to CD19 antigen on B cells.

The proposed 2027 budget would give HHS about $111.1 billion, down roughly $15.8 billion from its current funding. The plan comes from President Donald Trump, but Congress will decide what actually ...

KT may reduce pain intensity in immediate, short term and improve function/disability in immediate term, but evidence is ...

HealthDay News — Transcutaneous electrical nerve stimulation (TENS) plus outpatient physical therapy (PT) reduces movement-based pain in patients with fibromyalgia, according to a study published ...

HealthDay News — Treatment with upadacitinib is safe and effective for adults and adolescents with nonsegmental vitiligo (NSV), according to a study presented at the annual meeting of the American ...

The FDA is expected to decide on treatments for ADHD, Alzheimer disease, breast cancer, diabetes, and myasthenia gravis.

The TEPEZZA OBI trial evaluated the safety and efficacy of SC teprotumumab in patients with active TED and proptosis of 3mm or greater from baseline.

More than tripled risk of five-year mortality seen with use of complementary and alternative medicine alone compared with traditional therapies.